Seres Therapeutics Inc (MCRB) — Long-term Investment Intensity
Seres Therapeutics Inc (MCRB) has a Long-term Investment Intensity of 0.1% as of December 2021. Long-term investments of $495.00K represent 0.1% of total assets of $354.86 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. See Seres Therapeutics Inc net assets for net asset value and shareholders' equity analysis.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Seres Therapeutics Inc Long-term Investment Intensity (2014–2021)
This chart shows how Seres Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2014 to 2021. As of December 2021, the intensity stands at 0.1%, reflecting long-term investments of $495.00K against total assets of $354.86 Million USD. Also explore Seres Therapeutics Inc balance sheet assets for the complete picture of this company's asset base.
Annual Long-term Investment Intensity for Seres Therapeutics Inc (2014–2021)
The table below presents the year-by-year Long-term Investment Intensity for Seres Therapeutics Inc from 2014 to 2021, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see market value of Seres Therapeutics Inc.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.1% | $495.00K | $354.86 Million | ▼ -14.4 pp |
| 2020 | 14.5% | $49.83 Million | $342.94 Million | ▲ +13.5 pp |
| 2019 | 1.1% | $1.40 Million | $132.44 Million | ▼ -0.1 pp |
| 2018 | 1.2% | $1.40 Million | $120.47 Million | ▼ -12.3 pp |
| 2016 | 13.5% | $36.75 Million | $272.65 Million | ▼ -17.8 pp |
| 2014 | 31.3% | $36.75 Million | $117.34 Million | — |